3627 results for «2122»
3627 results
TAVI in cardiogenic shock
19 Nov 2023 – From PCR London Valves 2023
Because TAVI implantation, a routine procedure, is not always a breeze, look at a number of challenging cases, including a case of aortic stenosis complicated by cardiogenic shock, an emergency valve-in-valve TAVI, or a TAVI for left ventricular assist device.
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
Tricuspid valve interventions - Case studies
19 Nov 2023 – From PCR London Valves 2023
Explore a diverse range of tricuspid valve interventions through various case studies such as the multimodality percutaneous treatment of severe tricuspid regurgitation, Triclip subacute single leaflet detachment, bicaval valve implantation and more.
TAVI in complex scenarios
19 Nov 2023 – From PCR London Valves 2023
What do we mean by "complex scenarios"? When zero-contrast TAVI implantation becomes a good alternative in kidney disease, when TAVI is implanted in a patient with mechanical mitral valve, or when TAVI is implanted in very large annulus with subannular aneurysm, for example!
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
Tricuspid valve interventions in complex scenarios
20 Nov 2023 – From PCR London Valves 2023
Explore innovative tricuspid valve interventions with this selection of cases: witness the application of combined transcatheter tricuspid annuloplasty and edge-to-edge repair to address a torrential tricuspid regurgitation, discover a novel technique for uncrossable tricuspid valve-in-valve scenarios, delve into the management of severe tricuspid regurgitation in a...
Leaflet modification techniques
20 Nov 2023 – From PCR London Valves 2023
Discover cutting-edge leaflet modification approaches in transcatheter interventions with this selection of cases: explore the imaging aspects of the emerging ShortCut procedure for coronary protection in Valve-in-Valve TAVR, experience the effectiveness and simplicity of Balloon - Basilica for valve-in-valve interventions, learn about the adaptability of right...
TAVI - Coronary protection strategies
20 Nov 2023 – From PCR London Valves 2023
Consult this session for key insights into diverse coronary protection approaches: get a look at the management of a complex case involving a degenerated aortic bioprosthesis and paravalvular leak, observe a successful TAVI in calcified bicuspid anatomy with low coronaries, delve into a case featuring a degenerated...
TAVI in challenging aortic anatomy
20 Nov 2023 – From PCR London Valves 2023
Explore TAVI in challenging aortic anatomy through this selection of cases: navigate strategies for crossing severely adverse calcific bicuspid aortic valves in horizontal aortas, witness TAVI adaptability in cases of severe aortic stenosis with situs inversus totalis, learn about the complexities of TAVI implantation in patients...
TAVI - New indications, techniques and devices - Part 2
20 Nov 2023 – From PCR London Valves 2023
Consult this session for a swift overview of evolving TAVI indications and techniques: gain insights into thirty-day outcomes with Evolut FX, stratified by heart team risk, witness the 12-month follow-up of the Valvosoft first-in-man study, uncover sizing considerations in bicuspid tapered aortic valves undergoing TAVI from the...
Transcatheter mitral valve replacement
20 Nov 2023 – From PCR London Valves 2023
Consult this session for key insights into diverse TMVR challenges: discover unique scenarios such as para-holes post-Tendyne implant, TMVR in a patient with severe mitral annular calcification, a complex case involving mitral para-ring leak and stenosis with a two-step treatment and an atypical LAMPOON indication, and more!
TAVI - stroke
20 Nov 2023 – From PCR London Valves 2023
Join this session for key perspectives on stroke management and prevention in TAVI: gain a comprehensive view of the long-term outcomes in transfemoral TAVI complicated by stroke, evaluate a novel cerebral embolic protection during TAVI through the PROTEMBO C-TRIAL, learn how TAVR debris captured by CEP...
Aortic regurgitation - Part 1
20 Nov 2023 – From PCR London Valves 2023
Delve into key insights on aortic regurgitation with this selection of abstracts: explore a systematic review and meta-analysis on TAVI for aortic regurgitation using dedicated devices, witness video-densitometric analysis of aortic regurgitation post-JenaValve Trilogy treatment, discover a small case series on TAVI in the descending thoracic...
TAVI - New indications, techniques and devices - Part 3
20 Nov 2023 – From PCR London Valves 2023
Explore the latest in TAVI with this selection of abstracts: witness the application of valve-in-valve TAVI for failed sutureless surgical bioprostheses and gain insights from the analysis of the use and performance of the Evolut FX transcatheter aortic valve system.
TAVI - Alternative access - Part 2
20 Nov 2023 – From PCR London Valves 2023
Delve into alternative access strategies in TAVI with this session: navigate through cases featuring complex aortic anatomy in TAVI patients, witness the innovative use of intravascular lithotripsy of the abdominal aorta to facilitate transcaval valve-in-valve TAVR and explore the technique of transseptal TAVR.
New devices for tricuspid valve intervention
20 Nov 2023 – From PCR London Valves 2023
Join this session for a quick overview of groundbreaking devices shaping tricuspid valve interventions: witness the first-in-man experience with a cross-caval device designed for the treatment of tricuspid regurgitation, navigate through a challenging case involving a patient with massive tricuspid regurgitation and a permanent pacemaker lead and...
Mitral TEER - Part 1
20 Nov 2023 – From PCR London Valves 2023
Gain valuable insights into Mitral Transcatheter Edge-to-Edge Repair (TEER) with this session: explore the prognostic impact of post-procedural mitral regurgitation and gradient after TEER for primary mitral regurgitation and delve into the evolving landscape of same-day discharge following transcatheter edge-to-edge repair.
Complex tricuspid interventions
20 Nov 2023 – From PCR London Valves 2023
Consult this session to discover a selection of abstracts regarding tricuspid valve procedures: explore the complexities of long-term right heart remodeling after transcatheter tricuspid annuloplasty, witness the journey from pre-clinical studies to the first-in-man experience with MonarQ tricuspid valve replacement, delve into Tripair, an innovative transcatheter spacer...
TAVI in patients with coronary artery disease
20 Nov 2023 – From PCR London Valves 2023
Consult this session for a swift overview of navigating TAVI complexities in the presence of coronary artery disease: navigate through cases involving the management of severe aortic stenosis coupled with stable severe coronary artery disease, explore scenarios where valvular and coronary calcium present challenges, witness successful treatment...
TAVI in unusual clinical scenarios
20 Nov 2023 – From PCR London Valves 2023
Consult this session for a swift exploration of TAVI applications in unexpected clinical contexts: witness the challenges of TAVR in a patient with mucopolysaccharidosis type I, navigate through the complexities of TAVI in an orthotopic heart transplant recipient, explore the feasibility of TAVI in rheumatic severe...
